| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $147.5M | -0.4% | -16.3% |
| R&D Expense | $19.4M | -0.6% | -3.5% |
| SG&A Expense | $35.4M | +10.1% | +3.0% |
| Operating Income | $16.0M | +1.0% | +60.9% |
| Pre-tax Income | $7.1M | +0.7% | +183.8% |
| Income Tax | $1.2M | +0.3% | +68.1% |
| Net Income | $11.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $106.9M | -29.2% | +5.2% |
| Accounts Receivable | $36.8M | +4.7% | -26.3% |
| Current Assets | $236.2M | -15.4% | +19.8% |
| Total Assets | $1.40B | -1.1% | -3.3% |
| Current Liabilities | $116.9M | -0.9% | +7.4% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $90.2M | — | — |
| Capital Expenditures | $1.9M | — | — |
| Investing Cash Flow | -$56.5M | — | — |
| Financing Cash Flow | -$62.3M | — | — |
| Free Cash Flow | $88.3M | — | — |
| +36.3% |
| +221.4% |
| EPS (Basic) | $0.06 | +50.0% | +220.0% |
| EPS (Diluted) | $0.06 | +50.0% | +220.0% |
| $524.6M |
| -0.2% |
| -0.8% |
| Total Liabilities | $674.6M | -0.1% | -0.9% |
| Stockholders' Equity | $728.5M | -2.1% | -5.5% |